Metylfenidat Actavis Forðatafla 18 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metylfenidat actavis forðatafla 18 mg

actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 18 mg

Metylfenidat Actavis Forðatafla 27 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metylfenidat actavis forðatafla 27 mg

actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 27 mg

Metylfenidat Actavis Forðatafla 36 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metylfenidat actavis forðatafla 36 mg

actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 36 mg

Metylfenidat Actavis Forðatafla 54 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

metylfenidat actavis forðatafla 54 mg

actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 54 mg

Dimethyl fumarate Neuraxpharm Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Mylan Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Evrópusambandið - íslenska - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Tecfidera Evrópusambandið - íslenska - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dímetýl fúmarat - margvísleg sclerosis - Ónæmisbælandi lyf - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).